Page last updated: 2024-08-21

2-tert-butylhydroquinone and Protein Aggregation, Pathological

2-tert-butylhydroquinone has been researched along with Protein Aggregation, Pathological in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, DM; Daub, A; Finkbeiner, S; Finucane, MM; Hwang, V; Lee, AK; Modan, S; Ravisankar, A; Shaby, BA; Skibinski, G1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Protein Aggregation, Pathological

ArticleYear
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-31, Volume: 114, Issue:5

    Topics: alpha-Synuclein; Animals; Cerebral Cortex; Genes, Reporter; HEK293 Cells; Humans; Hydroquinones; Inclusion Bodies; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Nerve Tissue Proteins; Neurons; NF-E2-Related Factor 2; Parkinson Disease; Primary Cell Culture; Protein Aggregation, Pathological; Proteostasis; Rats; Recombinant Fusion Proteins; Single-Cell Analysis; Time Factors

2017